Saltar al contenido

The Science of Parkinson's

@scienceofpd.bsky.social did:plc:e4rz3xlsverunfboboqdap7i

Personal account of the Director of Research at Cure Parkinson's - All views my own - Kiwi - Kia kaha - 侘寂 - https://scienceofparkinsons.com/

En Bluesky desde el

Seguidores
857
Siguiendo
8
Posts
3.055
Días en rankings
0

Resumen

The Science of Parkinson's (@scienceofpd.bsky.social) es un usuario de Bluesky que se unió el 12 noviembre 2024. Tiene 857 seguidores, sigue a 8 cuentas y ha publicado 3.055 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • Cure Parkinson's@cureparkinsons.org.uk

    Less than 5% of people with Parkinson’s are taking part in clinical research studies. Let’s change that. We’re calling on MPs to pledge their support and declare “I support Cure Parkinson’s campaign to empower more people living with Parkinson’s to take part in research.” Join us: buff.ly/UwhLmz7

    Ver post
  • Cure Parkinson's@cureparkinsons.org.uk

    On Monday 16 November, Cure Parkinson's and France Parkinson are hosting an in-person and online public conference exploring how platform trials could accelerate the search for treatments that slow, stop or reverse Parkinson's. Book your place: buff.ly/W8gMg91

    Ver post
  • Cure Parkinson's@cureparkinsons.org.uk

    We are excited to announce that we have committed £1.4 million to several new projects focused on testing combination therapies for Parkinson’s. These involve a range of potentially disease-modifying treatments, targeting different aspects of Parkinson’s progression. Read more: buff.ly/ZDRBOOv

    Ver post
  • Cure Parkinson's@cureparkinsons.org.uk

    Results from Exenatide-PD3 sub-study, funded by Cure Parkinson’s, reveal a new way to predict Parkinson’s progression. Exenatide-PD3 was a phase 3 clinical trial of the Type 2 diabetes drug exenatide (Bydureon) which finished in early 2024. Find out more about the study: buff.ly/AjR8rjO

    Ver post
  • Cure Parkinson's@cureparkinsons.org.uk

    Missed our Parkinson’s and dementia webinar? You can now catch up with the recording, featuring Edinburgh University’s Professor Tilo Kunath and an expert panel discussing the relationship between Parkinson’s and dementia. Watch now: buff.ly/0G5VXkR

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.

Esta cuenta no bloquea a nadie.